Abstract
A new hypothesis has been proposed which states that microchimerism is the basis for the clinical tolerance seen in long-term survivors of solid organ transplants. Efforts to enhance microchimerism include simultaneous infusion of bone marrow of donor origin and transplantation of a solid organ. Studies are in progress to verify the phenomenon of microchimerism and its role in clinical tolerance.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson C. B., Brennan D., Keller C., Goss J., Shenoy S., Burton K., Sicard G., Flye M. W. Beneficial effects of donor-specific transfusions on long-term renal allograft function. Transplant Proc. 1995 Feb;27(1):991–994. [PubMed] [Google Scholar]
- BILLINGHAM R. E., BRENT L., MEDAWAR P. B. Actively acquired tolerance of foreign cells. Nature. 1953 Oct 3;172(4379):603–606. doi: 10.1038/172603a0. [DOI] [PubMed] [Google Scholar]
- Barber W. H., Diethelm A. G., Laskow D. A., Deierhoi M. H., Julian B. A., Curtis J. J. Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients. Transplantation. 1989 Jan;47(1):66–71. doi: 10.1097/00007890-198901000-00015. [DOI] [PubMed] [Google Scholar]
- Burdick J. F., Vogelsang G. B., Smith W. J., Farmer E. R., Bias W. B., Kaufmann S. H., Horn J., Colombani P. M., Pitt H. A., Perler B. A. Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med. 1988 Mar 17;318(11):689–691. doi: 10.1056/NEJM198803173181107. [DOI] [PubMed] [Google Scholar]
- Burlingham W. J., Grailer A. P., Fechner J. H., Jr, Kusaka S., Trucco M., Kocova M., Belzer F. O., Sollinger H. W. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation. 1995 Apr 27;59(8):1147–1155. [PubMed] [Google Scholar]
- Bushell A., Pearson T. C., Morris P. J., Wood K. J. Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence. Transplantation. 1995 May 27;59(10):1367–1371. doi: 10.1097/00007890-199505270-00001. [DOI] [PubMed] [Google Scholar]
- Fontes P., Rao A. S., Demetris A. J., Zeevi A., Trucco M., Carroll P., Rybka W., Rudert W. A., Ricordi C., Dodson F. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet. 1994 Jul 16;344(8916):151–155. doi: 10.1016/s0140-6736(94)92756-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gjertson D. W., Terasaki P. I., Takemoto S., Mickey M. R. National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs. N Engl J Med. 1991 Apr 11;324(15):1032–1036. doi: 10.1056/NEJM199104113241505. [DOI] [PubMed] [Google Scholar]
- Jindal R. M. Posttransplant diabetes mellitus--a review. Transplantation. 1994 Dec 27;58(12):1289–1298. [PubMed] [Google Scholar]
- Larsen C. P., Austyn J. M., Morris P. J. The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation. Ann Surg. 1990 Sep;212(3):308–317. doi: 10.1097/00000658-199009000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Levy A. E., Alexander J. W. Administration of intragraft interleukin-4 prolongs cardiac allograft survival in rats treated with donor-specific transfusion/cyclosporine. Transplantation. 1995 Sep 15;60(5):405–406. doi: 10.1097/00007890-199509000-00001. [DOI] [PubMed] [Google Scholar]
- Maki T., Gottschalk R., Wood M. L., Monaco A. P. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells. J Immunol. 1981 Oct;127(4):1433–1438. [PubMed] [Google Scholar]
- McDaniel D. O., Naftilan J., Hulvey K., Shaneyfelt S., Lemons J. A., Lagoo-Deenadayalan S., Hudson S., Diethelm A. G., Barber W. H. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation. 1994 Mar 27;57(6):852–856. doi: 10.1097/00007890-199403270-00014. [DOI] [PubMed] [Google Scholar]
- Miller R. G., Phillips R. A. Reduction of the in vitro cytotoxic lymphocyte response produced by in vivo exposure to semiallogeneic cells: recruitment or active suppression? J Immunol. 1976 Nov;117(5 PT2):1913–1921. [PubMed] [Google Scholar]
- Monaco A. P., Wood M. L., Maki T., Gozzo J. J. Post transplantation donor-specific bone marrow transfusion in polyclonal antilymphocyte serum-treated recipients: the optimal cellular antigen for induction of unresponsiveness to organ allografts. Transplant Proc. 1988 Dec;20(6):1207–1212. [PubMed] [Google Scholar]
- Murase N., Starzl T. E., Tanabe M., Fujisaki S., Miyazawa H., Ye Q., Delaney C. P., Fung J. J., Demetris A. J. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation. 1995 Jul 27;60(2):158–171. doi: 10.1097/00007890-199507000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakahori Y., Hamano K., Iwaya M., Nakagome Y. Sex identification by polymerase chain reaction using X-Y homologous primer. Am J Med Genet. 1991 Jun 15;39(4):472–473. doi: 10.1002/ajmg.1320390420. [DOI] [PubMed] [Google Scholar]
- Rolles K., Burroughs A. K., Davidson B. R., Karatapanis S., Prentice H. G., Hamon M. D. Donor-specific bone marrow infusion after orthotopic liver transplantation. Lancet. 1994 Jan 29;343(8892):263–265. doi: 10.1016/s0140-6736(94)91113-4. [DOI] [PubMed] [Google Scholar]
- Schlitt H. J., Raddatz G., Steinhoff G., Wonigeit K., Pichlmayr R. Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation. 1993 Oct;56(4):951–955. doi: 10.1097/00007890-199310000-00033. [DOI] [PubMed] [Google Scholar]
- Shapiro R., Rao A. S., Fontes P., Jordan M., Scantlebury V. P., Vivas C., Demetris A. J., Zeevi A., Rybka W., Carroll P. Combined kidney/bone marrow transplantation--evidence of augmentation of chimerism. Transplantation. 1995 Jan 27;59(2):306–309. doi: 10.1097/00007890-199501000-00026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Starzl T. E. Cell migration and chimerism--a unifying concept in transplantation--with particular reference to HLA matching and tolerance induction. Transplant Proc. 1993 Feb;25(1 Pt 1):8–12. [PubMed] [Google Scholar]
- Starzl T. E., Demetris A. J., Trucco M., Murase N., Ricordi C., Ildstad S., Ramos H., Todo S., Tzakis A., Fung J. J. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 1993 Jun;17(6):1127–1152. [PMC free article] [PubMed] [Google Scholar]
- Starzl T. E., Demetris A. J., Trucco M., Ramos H., Zeevi A., Rudert W. A., Kocova M., Ricordi C., Ildstad S., Murase N. Systemic chimerism in human female recipients of male livers. Lancet. 1992 Oct 10;340(8824):876–877. doi: 10.1016/0140-6736(92)93286-v. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Starzl T. E., Demetris A. J., Trucco M., Zeevi A., Ramos H., Terasaki P., Rudert W. A., Kocova M., Ricordi C., Ildstad S. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation. 1993 Jun;55(6):1272–1277. doi: 10.1097/00007890-199306000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Starzl T. E., Murase N., Thomson A., Demetris A. J. Liver transplants contribute to their own success. Nat Med. 1996 Feb;2(2):163–165. doi: 10.1038/nm0296-163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steinman R. M., Inaba K., Austyn J. M. Donor-derived chimerism in recipients of organ transplants. Hepatology. 1993 Jun;17(6):1153–1156. [PubMed] [Google Scholar]
- Suberbielle C., Caillat-Zucman S., Legendre C., Bodemer C., Noël L. H., Kreis H., Bach J. F. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet. 1994 Jun 11;343(8911):1468–1469. doi: 10.1016/s0140-6736(94)92583-6. [DOI] [PubMed] [Google Scholar]
- Swain S. L., Weinberg A. D., English M., Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol. 1990 Dec 1;145(11):3796–3806. [PubMed] [Google Scholar]
- Taniguchi H., Toyoshima T., Fukao K., Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nat Med. 1996 Feb;2(2):198–203. doi: 10.1038/nm0296-198. [DOI] [PubMed] [Google Scholar]
- Thomson L., Donaldson P., Doherty D., Devlin J., Williams R. Detection of donor-specific microchimerism following liver transplantation. Transplantation. 1995 Oct 15;60(7):769–770. doi: 10.1097/00007890-199510150-00029. [DOI] [PubMed] [Google Scholar]
- Tiercy J. M., Morel C., Freidel A. C., Zwahlen F., Gebuhrer L., Bétuel H., Jeannet M., Mach B. Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7121–7125. doi: 10.1073/pnas.88.16.7121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Valdivia L. A., Demetris A. J., Langer A. M., Celli S., Fung J. J., Starzl T. E. Dendritic cell replacement in long-surviving liver and cardiac xenografts. Transplantation. 1993 Aug;56(2):482–484. doi: 10.1097/00007890-199308000-00048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weber J. L., May P. E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet. 1989 Mar;44(3):388–396. [PMC free article] [PubMed] [Google Scholar]
- Yamaguchi Y., Halperin E. C., Mori K., Misumi M., Katsumori T., Takata N., Goto M., Makino Y., Kikuchi N., Takahashi K. Macrophage migration into hepatic xenografts in the hamster-to-rat combination. Transplant Proc. 1991 Feb;23(1 Pt 1):220–221. [PubMed] [Google Scholar]
- van Twuyver E., Kast W. M., Mooijaart R. J., Melief C. J., De Waal L. P. Induction of transplantation tolerance by intravenous injection of allogeneic lymphocytes across an H-2 class II mismatch. Different mechanisms operate in tolerization across an H-2 class I vs. H-2 class II disparity. Eur J Immunol. 1990 Feb;20(2):441–444. doi: 10.1002/eji.1830200232. [DOI] [PubMed] [Google Scholar]
